A Phase 1/2 Study of Umbralisib, Ublituximab, and Venetoclax in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)

Drug Category: Array
Conference Category: Array
Lead Author: Barr, P et al.
Published Date: 19/09/2021
Download Link: /wp-content/uploads/2021/09/dk-barr-test-pdf-Rev3-9.17.21.pdf
Download Text: Download
Popup Confirmation?:
site-sidebar-layout: default
ast-site-content-layout: default
site-content-style: default
site-sidebar-style: default
theme-transparent-header-meta: default
stick-header-meta: default
astra-migrate-meta-layouts: set
Scroll to Top